A new review of literature on COVID-19–sniffing canines shows dogs outperformed or matched reverse-transcription polymerase chain reaction (RT-PCR) tests or antigen tests in detecting the novel coronavirus among humans or patient samples containing sweat, saliva, or urine.…
For the first time, researchers have calculated excess deaths among US dementia patients during the pandemic, and they found a reduction in excess mortality among long-term care residents after COVID-19 vaccines were made available. The study was…
In a statement yesterday, the World Health Organization (WHO) said the surveillance of human contact of cats infected with H5N1 avian flu in Poland has wrapped up, and none have reported symptoms, and it put the risk…
A new study published in JAMA finds that fewer than one in five US nursing home residents received evidenced-based treatment with monoclonal antibodies or oral antiviral drugs for COVID-19, despite being at high risk for poor outcomes. The rate…
A team led by a neurodevelopment researcher from the University of Texas at Dallas has uncovered some of the most compelling evidence to date showing parents who talk to their newborns more boost their brain…
Only the wearer knows where the shoe pinches. Well, that’s true, at least in my case. For months, I was struggling post-Covid. Little did I know that there were many others, too, who were wearing…
The UK Health Security Agency (HSA) today reported two more asymptomatic H5N1 avian flu detections in people who had contact with sick poultry, raising the country's total to four from its ongoing surveillance program. In…
A cohort study today shows that 75% of US hospitals had a positive net operating income in 2020 and 2021, with many seeing operating margins reach all-time highs, suggesting COVID-19 relief funds may have been larger than…
The Finnish Food Authority (FFA) today reported an H5N1 avian flu outbreak in blue foxes at a fur farm in Kausti, located in the west central part of the country. The agency said the virus is the…
Cancer patients and survivors in Singapore derived significant protection from severe COVID-19 after three or four vaccine doses for at least 5 months, according to a nationwide study published today in JAMA Oncology. Led by National Cancer Centre…
